Cleerly AI-QCT Demonstrates High Agreement With Invasive IVUS in INVICTUS Registry
Multicenter INVICTUS Registry Demonstrates Strong Correlation Between Noninvasive AI-QCT and Invasive IVUS for Coronary Plaque Quantification
Aetna Approves Coverage for Cleerly's AI Cardiovascular Imaging Analysis
Major Insurer Joins UnitedHealthcare, Cigna, and Humana in Covering Cleerly's AI-QCT Technology as Industry Momentum Builds with 86+ Million Lives...
CVCT 2025: Cleerly Late-Breaking Science Identifies Thresholds of High Plaque Burden in Non-Obstructive CAD that May Carry Greater Risk Than Obstructive Disease
Sixth late-breaking presentation from CONFIRM2 Registry demonstrates 12-fold risk gradient based on total plaque burden
Cleerly Unveils PowerScribe Integration and Lesion-Level Reporting at RSNA 2025
New additions streamline data transfer with lesion details, helping make information more accessible for care teams
